Special Autumn 2026Preview: CROs & CDMOsCDMOs and CROs need to integrate new clinical trial designs, innovative drug modalities, and AI into their service portfolios. At the same time, they are facing a shortage of qualified personnel. more ➔
Special Autumn 2026Preview: Autoimmune & inflammatory diseasesTreatment options for autoimmune and inflammatory diseases are evolving from blanket immunosuppression towards more targeted approaches. more ➔
Special Summer 2026Special: RNA TechnologiesThe COVID-19 pandemic demonstrated the efficacy of mRNA vaccine delivery, and other applications, particularly in oncology, are now being explored. more ➔
Special Summer 2026Special: Drug Delivery ServicesFor years, drug delivery sat downstream of discovery but that hierarchy is changing. In a market shaped by biologics, chronic disease, payer pressure and overloaded health systems, how a medicine reaches … more ➔
Special Spring 2026Special: Lab automation + data scienceLaboratory automation is evolving fast. What used to be a patchwork of isolated device solutions has steadily moved toward smarter, interconnected labs. And now that robotics is pushing the field one … more ➔
Special Spring 2026Special: CDMO Landscape EuropeToday, 90% of biotechs outsource manufacturing to CDMOs. Outsourcing decisions are no longer straightforward cost-benefit analyses. Geopolitical volatility and unprecedented demand for advanced modalities … more ➔
Special Winter 2025Euro BioFairs CompassGuide to European Life Sciences Events in the first half year of 2026 more ➔
Special Autumn 2025CDMOs & CROsThe Trump administration’s trade policy has hit CDMOs and CROs hard. Trade barriers against Chinese service providers and raw material suppliers have increased biologics production costs and caused … more ➔
Special Summer 2025Euro BioFairs CompassGuide to Life Sciences Events in the second half year of 2025 more ➔
Special Summer 2025(Bio)EngineeringRegions and industry leaders are already preparing for the future. This Special spotlights emerging open innovation clusters and cutting-edge bioengineering platforms. more ➔
